|
Related Articles |
GeneReviews(®)
Book. 1993
Authors: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K
Abstract
CLINICAL CHARACTERISTICS: TRIO-related intellectual disability (ID) is characterized by delay in acquisition of motor and language skills, mild to borderline intellectual disability, and neurobehavioral problems (including autistic traits or autism spectrum disorder, attention deficit hyperactivity disorder, and/or aggression). Neonatal or infantile feeding difficulties including poor suck, impaired bottle feeding, and failure to thrive are common and are often the presenting finding. Other findings can include microcephaly, variable hand and dental abnormalities, and suggestive facial features. Only ten of the 20 individuals with a TRIO pathogenic variant reported to date had sufficient information to make preliminary generalizations about clinical manifestations; it is anticipated that the phenotype of this newly described disorder will continue to evolve.
DIAGNOSIS/TESTING: The diagnosis of TRIO-related ID is established in a proband by identification of a heterozygous TRIO pathogenic variant on molecular genetic testing.
MANAGEMENT: Treatment of manifestations: Treatment is symptomatic and includes routine management of developmental delays/ID, social and behavior problems, feeding difficulty, and dental abnormalities. Surveillance: Regular dietary evaluation in infancy to ensure optimal nutritional status; monitoring of developmental progress and educational needs; behavioral assessment for attention, aggression, and/or social communication difficulties; regular dental evaluations.
GENETIC COUNSELING: TRIO-related ID is inherited in an autosomal dominant manner. The majority of affected individuals have the disorder as the result of a de novo pathogenic variant; between 20% and 40% have inherited the TRIO pathogenic variant from a similarly affected parent. Each child of an individual with TRIO-related ID has a 50% chance of inheriting the TRIO pathogenic variant. Once the TRIO pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.
PMID: 28796471
via https://www.ncbi.nlm.nih.gov/pubmed/28796471?dopt=Abstract

